Holen Sie sich die Stockscreener-App
323.81
5.13%
-17.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$341.41
Offen:
$350.25
24-Stunden-Volumen:
2.07M
Relative Volume:
1.23
Marktkapitalisierung:
$82.48B
Einnahmen:
$70.60B
Nettoeinkommen (Verlust:
$5.76B
KGV:
14.74
EPS:
21.97
Netto-Cashflow:
$5.64B
1W Leistung:
-3.32%
1M Leistung:
-3.73%
6M Leistung:
-10.91%
1J Leistung:
+3.11%
1-Tages-Spanne:
$321.39
$350.25
1-Wochen-Bereich:
$314.43
$350.25
52-Wochen-Spanne:
$289.98
$417.14
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Vergleichen Sie HCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
323.80 | 82.48B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.45 | 13.88B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
121.20 | 12.14B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
172.06 | 11.40B | 15.42B | 1.03B | 956.84M | 15.02 |
|
DVA
Davita Inc
|
139.10 | 11.20B | 12.67B | 827.68M | 1.42B | 9.27 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare Q1 Earnings Beat on Growing Patient Volumes - Zacks Investment Research
HCA Healthcare Reports Upbeat Q1 Earnings, Reaffirms 2025 Guidance: Retail Stays Optimistic - MSN
HCA Healthcare Tops First-Quarter Views, Affirms Full-Year Outlook - marketscreener.com
HCA Healthcare posts higher profit on strong demand for medical care - MSN
HCA Healthcare beats profit estimates on strong demand for medical care - MSN
HCA Healthcare Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Compared to Estimates, HCA (HCA) Q1 Earnings: A Look at Key Metrics - Nasdaq
HCA Healthcare (HCA) Maintains Quarterly Dividend - GuruFocus
HCA Healthcare Shows Strong Pulse In Q1, Keeps 2025 Outlook Healthy - Benzinga
HCA Healthcare Inc Surpasses Q1 2025 Estimates with EPS of $6.45 and Revenue of $18.321 Billion - GuruFocus
HCA Healthcare (HCA) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
HCA Healthcare Reports First Quarter 2025 Results | HCA Stock Ne - GuruFocus
HCA Healthcare Q1 2025 Financial Results Announced - TipRanks
HCA Healthcare's Q1 Adjusted Earnings, Revenue Rise; Reaffirms Full Year Outlook - marketscreener.com
HCA: Q1 Earnings Snapshot - CTPost
HCA Healthcare posts higher profit on strong demand for medical care By Reuters - Investing.com
HCA Healthcare Reaffirms FY25 OutlookUpdate - Nasdaq
HCA Healthcare Beats Profit Estimates on Strong Demand for Medical Care - Money/ US News
HCA Healthcare’s (NYSE:HCA) Q1 Sales Top Estimates - Yahoo Finance
HCA Healthcare tops Q1 estimates, reaffirms 2025 outlook - Investing.com Australia
HCA Healthcare, Inc. Q1 Profit Increases, Beats Estimates - Nasdaq
HCA Healthcare Delivers Strong Q1 2025: Revenue Surges to $18.3B with Rising Hospital Admissions - Stock Titan
HCA Healthcare Reports First Quarter 2025 Results - The Joplin Globe
Wolfe Research Adjusts HCA Healthcare Price Target to $355 From $348 - marketscreener.com
What To Expect From HCA Healthcare’s (HCA) Q1 Earnings - Yahoo Finance
Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA - Yahoo Finance
HCA HEALTHCARE Earnings Preview: Recent $HCA Insider Trading, Hedge Fund Activity, and More - Nasdaq
HCA veterans raise $10 million to launch PathPoint Health - The Business Journals
HCA Healthcare to Report Q1 Earnings: Key Estimates to Note - Yahoo Finance
HCA Healthcare's SWOT analysis: stock outlook amid growth and challenges - MSN
Former HCA exec Marty Paslick: Connection is the key to health care's future - The Business Journals
Exploring Analyst Estimates for HCA (HCA) Q1 Earnings, Beyond Revenue and EPS - Yahoo Finance
Despite Regulatory Uncertainties, HCA Healthcare Looks Healthy (NYSE:HCA) - Seeking Alpha
HCA Healthcare Inc (HCA) Shares Gap Down to $315.875 on Apr 21 - GuruFocus
HCA Healthcare Inc. stock underperforms Monday when compared to competitors - MarketWatch
HCA, Workers Eye Mediation in Wage Suit - Law360
Universal Health (UHS) Shares React to Medicaid Program Discussions | HCA Stock News - GuruFocus
Earth Day with HCA - StyleBlueprint
HCA Healthcare Stock: Is Wall Street Bullish or Bearish? - MSN
(HCA) Investment Analysis and Advice - news.stocktradersdaily.com
Baird Downgrades HCA Healthcare (BIT:1HCA) - Nasdaq
Why We Like The Returns At HCA Healthcare (NYSE:HCA) - Yahoo Finance
Baird Downgrades HCA Healthcare (HCA) - MSN
HCA Healthcare (HCA) Downgraded by Baird Amid Policy Uncertainties | HCA Stock News - GuruFocus
Recognizing nursing excellence: HCA Healthcare announces 2024 Unit of Distinction Awards - HCA Healthcare Today
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Baird Downgrades HCA Healthcare Inc to Neutral From Outperform, Adjusts PT to $336 From $396 - marketscreener.com
HCA Florida breaks ground on $15M project in Apopka - WFTV
Hospital workers demand safer working conditions after nurse attacked in Palm Beach County - WFLX
Earnings Preview: What to Expect From HCA Healthcare's Report - Nasdaq
What for-profit systems' top execs earned in 2024 - Modern Healthcare
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.21%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):